Four cycles of paclitaxel and carboplatin as adjuvant treatment in early-stage ovarian cancer: a six-year experience of the Hellenic Cooperative Oncology Group - Concepedia

Concepedia

Publication | Open Access

Four cycles of paclitaxel and carboplatin as adjuvant treatment in early-stage ovarian cancer: a six-year experience of the Hellenic Cooperative Oncology Group

DOI Full Paper Access

12

Citations

25

References

2006

Year

Aristotle Bamias, Christos Papadimitriou, Eleni Efstathiou, Alexandros Rodolakis, Georgios Vlahos, Zannis Voulgaris, Gerasimos Aravantinos, Evagelia Razis, Dimitra Gika, Meletios Α. Dimopoulos

Abstract

Paclitaxel/Carboplatin chemotherapy is a safe and effective adjuvant treatment in early-stage ovarian carcinoma. Patients with stages Ic-IIb and tumor grade 2 or 3 may benefit from more extensive treatment.

References

	Year	Citations
Nonparametric Estimation from Incomplete Observations Edward L. Kaplan, Paul Meier Journal of the American Statistical Association EngineeringAgingLife PredictionRare Event EstimationMortality Rates	1958	38.7K
Nonparametric Estimation from Incomplete Observations Edward L. Kaplan, Paul Meier Journal of the American Statistical Association EngineeringAgingLife PredictionRare Event EstimationMortality Rates	1958	7.7K
Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer William P. McGuire, William J. Hoskins, Mark F. Brady, New England Journal of Medicine	1996	2.9K
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study Robert F. Ozols, Brian N. Bundy, Benjamin E. Greer, Journal of Clinical Oncology	2003	2K
Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year Results M. Piccart JNCI Journal of the National Cancer Institute	2000	1K
Impact of Adjuvant Chemotherapy and Surgical Staging in Early-Stage Ovarian Carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm Trial J. Baptist Trimbos, Ignace Vergote, Giorgio Bolis, JNCI Journal of the National Cancer Institute	2003	679
Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma Ignace Vergote, Jos De Brabanter, Anthony Fyles, The Lancet MedicineSurgical PathologyEpithelial Ovarian CarcinomaPathologyGynecology	2001	626
Adjuvant Therapy in Stage I and Stage II Epithelial Ovarian Cancer Robert C. Young, Leslie A. Walton, Susan S. Ellenberg, New England Journal of Medicine Surgical OncologyGynecological SurgeryHealth SciencesMedicineMetronomic Therapy	1990	590
Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial The Lancet OncologyMedicineSingle-agent CarboplatinMetronomic TherapyGynecology	2002	557
Staging Laparotomy in Early Ovarian Cancer Robert C. Young JAMA LaparoscopySurgical OncologyGynecologic SurgeryGynecological SurgeryMedicine	1983	502

Page 1